-
1 week ago | 
mondaq.com | Theresa C. Carnegie |Xavier G. Hardy |Samantha Hawkins |Abdie Santiago
M Mintz More Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
-
Jan 30, 2025 | 
mondaq.com | Rachel Alexander |Theresa C. Carnegie |Tara Dwyer |Joseph Miller
M Mintz More Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
-
Nov 25, 2024 | 
jdsupra.com | Rachel Alexander |Theresa C. Carnegie |Madison Castle
Mintz’s PBM practice is pleased to present its quarterly publication, PBM Policy and Legislative Update. This edition builds upon prior issues and summarizes activity from July through September that affects the PBM industry. It highlights (i) federal legislative activity and oversight, (ii) state legislative activity and oversight, and (iii) other noteworthy events and trends affecting the PBM industry.
We hope you find the PBM Policy and Legislative Update to be a useful resource.
-
Aug 20, 2024 | 
lexology.com | Rachel Alexander |Theresa C. Carnegie |Xavier G. Hardy |Alison Peters |Madison Castle
On August 15, 2024, CMS announced the results of the first round of the negotiated prices between CMS and participating drug manufacturers for the 10 selected drugs under the Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program (MPN or Program).
-
Aug 1, 2024 | 
jdsupra.com | Rachel Alexander |Theresa C. Carnegie |Madison Castle
Mintz’s PBM practice is pleased to present a 2024 year-to-date PBM Policy and Legislative Update. This edition builds upon prior issues and summarizes activity from January through June that impacts the PBM industry. It specifically highlights federal legislative activity and oversight, state legislation and litigation, and other noteworthy events and trends affecting the PBM industry.
Please see full publication below for more information.
-
Jul 31, 2024 | 
natlawreview.com | Theresa C. Carnegie
Skip to main content July 31, 2024 Volume XIV, Number 213 Legal Analysis. Expertly Written. Quickly Found.
-
Jul 31, 2024 | 
lexology.com | Theresa C. Carnegie |Rachel Alexander |Madison Castle |Xavier G. Hardy |Stephnie A. John |Alison Peters | +8 more
The PBM regulatory landscape is rapidly evolving at both federal and state levels, making it critical for our clients involved in the PBM space to stay apprised of developments in the industry as they happen. Our team actively monitors these developments to provide you with this PBM Policy and Legislative Update. This update builds on prior issues and highlights federal and state activity from January 2024 through June 2024.
-
Jul 31, 2024 | lexology.com | Theresa C. Carnegie |Rachel Alexander |Madison Castle |Xavier G. Hardy |Stephnie A. John |Alison Peters | +8 more
The PBM regulatory landscape is rapidly evolving at both federal and state levels, making it critical for our clients involved in the PBM space to stay apprised of developments in the industry as they happen. Our team actively monitors these developments to provide you with this PBM Policy and Legislative Update. This update builds on prior issues and highlights federal and state activity from January 2024 through June 2024.
-
Jul 15, 2024 | 
jdsupra.com | Rachel Alexander |Theresa C. Carnegie |Tara Dwyer
July 15, 2024 Rachel Alexander, Theresa Carnegie, Tara Dwyer, Samantha Hawkins, Bridgette Keller, Joseph Miller, Hassan Shaikh, Payton Thornton Mintz - Antitrust Viewpoints + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: The Federal Trade Commission (FTC) Office of Policy Planning released an Interim Staff Report titled Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies...
-
Jul 15, 2024 | 
mondaq.com | Rachel Alexander |Theresa C. Carnegie |Tara Dwyer |Joseph Miller
The Federal Trade Commission (FTC) Office of Policy Planning
released an Interim Staff Report titled Pharmacy Benefit
Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing
Main Street Pharmacies (the Interim Report) on July 9, 2024. The Interim Report reflects the FTC's work since it began its
6(b) study of Pharmacy Benefit Managers (PBMs) in June 2022.
